191 related articles for article (PubMed ID: 15014065)
1. Nosocomial bloodstream infections due to viridans streptococci in haematological and non-haematological patients: species distribution and antimicrobial resistance.
Lyytikäinen O; Rautio M; Carlson P; Anttila VJ; Vuento R; Sarkkinen H; Kostiala A; Väisänen ML; Kanervo A; Ruutu P
J Antimicrob Chemother; 2004 Apr; 53(4):631-4. PubMed ID: 15014065
[TBL] [Abstract][Full Text] [Related]
2. Clinical features and complications of viridans streptococci bloodstream infection in pediatric hemato-oncology patients.
Huang WT; Chang LY; Hsueh PR; Lu CY; Shao PL; Huang FY; Lee PI; Chen CM; Lee CY; Huang LM
J Microbiol Immunol Infect; 2007 Aug; 40(4):349-54. PubMed ID: 17712470
[TBL] [Abstract][Full Text] [Related]
3. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study.
Wisplinghoff H; Bischoff T; Tallent SM; Seifert H; Wenzel RP; Edmond MB
Clin Infect Dis; 2004 Aug; 39(3):309-17. PubMed ID: 15306996
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial resistance of community-acquired bloodstream isolates of viridans group streptococci.
Yap RL; Mermel LA; Maglio J
Infection; 2006 Dec; 34(6):339-41. PubMed ID: 17180589
[TBL] [Abstract][Full Text] [Related]
5. Prospective national survey of viridans streptococcal bacteraemia risk factors, antibacterial susceptibility and outcome of 120 episodes.
Mrazova M; Docze A; Buckova E; Bucko L; Kacmarikova M; Grey E; Korcova J; Koprnova J; Saboova Z; Beno P; Karvaj M; Svetlansky I; Ondrus A; Benca J; Taziarova M; Rudinsky B; Krcmery V
Scand J Infect Dis; 2005; 37(9):637-41. PubMed ID: 16126562
[TBL] [Abstract][Full Text] [Related]
6. Effect of benzathine penicillin treatment on antibiotic susceptibility of viridans streptococci in oral flora of patients receiving secondary prophylaxis after rheumatic fever.
Bilavsky E; Eliahou R; Keller N; Yarden-Bilavsky H; Harel L; Amir J
J Infect; 2008 Apr; 56(4):244-8. PubMed ID: 18295897
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial susceptibility patterns and macrolide resistance genes of viridans group streptococci from blood cultures in Korea.
Uh Y; Shin DH; Jang IH; Hwang GY; Lee MK; Yoon KJ; Kim HY
J Antimicrob Chemother; 2004 Jun; 53(6):1095-7. PubMed ID: 15117924
[TBL] [Abstract][Full Text] [Related]
8. Predominance of Gram-negative bacilli and increasing antimicrobial resistance in nosocomial bloodstream infections at a university hospital in southern Taiwan, 1996-2003.
Wu CJ; Lee HC; Lee NY; Shih HI; Ko NY; Wang LR; Ko WC
J Microbiol Immunol Infect; 2006 Apr; 39(2):135-43. PubMed ID: 16604246
[TBL] [Abstract][Full Text] [Related]
9. Levofloxacin vs. ciprofloxacin plus phenethicillin for the prevention of bacterial infections in patients with haematological malignancies.
Timmers GJ; Simoons-Smit AM; Leidekker ME; Janssen JJ; Vandenbroucke-Grauls CM; Huijgens PC
Clin Microbiol Infect; 2007 May; 13(5):497-503. PubMed ID: 17263835
[TBL] [Abstract][Full Text] [Related]
10. Viridans group streptococci in blood culture isolates in a Swedish university hospital: antibiotic susceptibility and identification of erythromycin resistance genes.
Westling K; Julander I; Ljungman P; Jalal S; Nord CE; Wretlind B
Int J Antimicrob Agents; 2006 Oct; 28(4):292-6. PubMed ID: 16938436
[TBL] [Abstract][Full Text] [Related]
11. Nosocomial streptococcal blood stream infections in the SCOPE Program: species occurrence and antimicrobial resistance. The SCOPE Hospital Study Group.
Pfaller MA; Jones RN; Marshall SA; Edmond MB; Wenzel RP
Diagn Microbiol Infect Dis; 1997 Dec; 29(4):259-63. PubMed ID: 9458983
[TBL] [Abstract][Full Text] [Related]
12. Erythromycin and penicillin resistance mechanisms among viridans group streptococci isolated from blood cultures of adult patients with underlying diseases.
Ergin A; Eser ÖK; Hasçelik G
New Microbiol; 2011 Apr; 34(2):187-93. PubMed ID: 21617831
[TBL] [Abstract][Full Text] [Related]
13. Nosocomial bloodstream infections in Finnish hospitals during 1999-2000.
Lyytikäinen O; Lumio J; Sarkkinen H; Kolho E; Kostiala A; Ruutu P;
Clin Infect Dis; 2002 Jul; 35(2):e14-9. PubMed ID: 12087538
[TBL] [Abstract][Full Text] [Related]
14. Population structure and characterization of viridans group streptococci (VGS) including Streptococcus pneumoniae isolated from adult patients with cystic fibrosis (CF).
Maeda Y; Elborn JS; Parkins MD; Reihill J; Goldsmith CE; Coulter WA; Mason C; Millar BC; Dooley JS; Lowery CJ; Ennis M; Rendall JC; Moore JE
J Cyst Fibros; 2011 Mar; 10(2):133-9. PubMed ID: 21145793
[TBL] [Abstract][Full Text] [Related]
15. [Phenotypes and genetic mechanisms of resistance to macrolides and lincosamides in viridans group streptococci].
Artiles Campelo F; Horcajada Herrera I; Alamo Antúnez I; Cãnas Pedrosa A; Lafarga Capuz B
Rev Esp Quimioter; 2007 Sep; 20(3):317-22. PubMed ID: 18080028
[TBL] [Abstract][Full Text] [Related]
16. Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States.
Wisplinghoff H; Seifert H; Wenzel RP; Edmond MB
Clin Infect Dis; 2003 May; 36(9):1103-10. PubMed ID: 12715303
[TBL] [Abstract][Full Text] [Related]
17. Genotypic analysis of Acinetobacter bloodstream infection isolates in a Turkish university hospital.
Alp E; Esel D; Yildiz O; Voss A; Melchers W; Doganay M
Scand J Infect Dis; 2006; 38(5):335-40. PubMed ID: 16709534
[TBL] [Abstract][Full Text] [Related]
18. Macrolide resistance mechanisms and in vitro susceptibility patterns of viridans group streptococci isolated from blood cultures.
Ergin A; Ercis S; Hasçelik G
J Antimicrob Chemother; 2006 Jan; 57(1):139-41. PubMed ID: 16291867
[TBL] [Abstract][Full Text] [Related]
19. Surveillance of antimicrobial resistance at a tertiary hospital in Tanzania.
Blomberg B; Mwakagile DS; Urassa WK; Maselle SY; Mashurano M; Digranes A; Harthug S; Langeland N
BMC Public Health; 2004 Oct; 4():45. PubMed ID: 15476559
[TBL] [Abstract][Full Text] [Related]
20. Viridans streptococcus bacteremia in children on chemotherapy for cancer: an underestimated problem.
Ahmed R; Hassall T; Morland B; Gray J
Pediatr Hematol Oncol; 2003 Sep; 20(6):439-44. PubMed ID: 14631617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
